Omeprazole Towa Pharmaceutical Europe (Omeprazole)

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑esophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑induced ulcer prophylaxis: lowers the risk of ulcer development in patients requiring long‑term non‑steroidal anti‑inflammatory drugs.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells. By inhibiting this final step of acid production, it markedly reduces both basal and stimulated gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea or vomiting: occasional.
• Abdominal pain or flatulence: mild discomfort.
• Constipation: infrequent.
• Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis): requires immediate medical attention.
• Clostridioides difficile infection: may present with persistent diarrhea.
• Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia.
• Bone fractures: increased risk with long‑term use.
• Liver enzyme elevation: may indicate hepatic stress.
• Acute interstitial nephritis: rare kidney inflammation.

Before initiating therapy, consider the following precautions:

• Pregnancy: discuss risks and benefits with a healthcare professional.
• Breastfeeding: evaluate infant exposure risk.
• Renal or hepatic impairment: dose may need adjustment.
• Long‑term use: monitor for vitamin B12 deficiency and bone health.
• Drug interactions: review concomitant medications for potential interactions.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect may increase cardiovascular risk.
• Atazanavir or other protease inhibitors: decreased absorption leading to therapeutic failure.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR; monitor coagulation parameters.
• Methotrexate: possible accumulation; check serum levels.
• Digoxin: enhanced absorption may raise serum concentrations.
• Diazepam: increased plasma levels may cause sedation.
• Iron supplements: reduced absorption; separate dosing by at least 2 hours.